{"component": "definition", "props": {"groups": [{"size": 316, "snippet": "means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.", "snippet_links": [{"key": "pharmaceutical-product", "type": "definition", "offset": [10, 32]}, {"key": "licensed-compound", "type": "definition", "offset": [46, 63]}, {"key": "other-active-ingredients", "type": "clause", "offset": [79, 103]}], "samples": [{"hash": "gtkXHUyyiQD", "uri": "/contracts/gtkXHUyyiQD#licensed-product", "label": "Sublicense Agreement (Ligand Pharmaceuticals Inc)", "score": 33.1587944031, "published": true}, {"hash": "2QGbemhZV9e", "uri": "/contracts/2QGbemhZV9e#licensed-product", "label": "Sublicense Agreement (Ligand Pharmaceuticals Inc)", "score": 31.1546878815, "published": true}, {"hash": "eDmSFWeJ1dG", "uri": "/contracts/eDmSFWeJ1dG#licensed-product", "label": "License Agreement (Spero Therapeutics, Inc.)", "score": 28.8083496094, "published": true}], "hash": "fade331621656f4d15ce10ae04742891", "id": 1}, {"size": 306, "snippet": "means a product or part of a product in the Licensed Field of Use:\n(A) the making, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent; or\n(B) which is made with, uses or incorporates any Technology.", "snippet_links": [{"key": "licensed-field-of-use", "type": "definition", "offset": [44, 65]}, {"key": "infringement-of", "type": "clause", "offset": [193, 208]}, {"key": "licensed-patent", "type": "definition", "offset": [211, 226]}], "samples": [{"hash": "dMtZnYSDwmf", "uri": "/contracts/dMtZnYSDwmf#licensed-product", "label": "Exclusive Equity Agreement (Medicenna Therapeutics Corp.)", "score": 33.4709091187, "published": true}, {"hash": "4r1NKlPfN0v", "uri": "/contracts/4r1NKlPfN0v#licensed-product", "label": "Exclusive Equity Agreement (Medicenna Therapeutics Corp.)", "score": 33.4709091187, "published": true}, {"hash": "e8YVXwoDADi", "uri": "/contracts/e8YVXwoDADi#licensed-product", "label": "Exclusive (Equity) Agreement (Consonance-HFW Acquisition Corp.)", "score": 32.4770698547, "published": true}], "hash": "9212ca6b23a550177ac7f6db10cdaeef", "id": 2}, {"size": 213, "snippet": "means any product or component (i) whose manufacture, use, sale, offer for sale or import is covered by any Valid Claim, or (ii) which is made using a Licensed Process or another Licensed Product.", "snippet_links": [{"key": "offer-for-sale", "type": "definition", "offset": [65, 79]}, {"key": "covered-by", "type": "definition", "offset": [93, 103]}, {"key": "valid-claim", "type": "definition", "offset": [108, 119]}, {"key": "licensed-process", "type": "definition", "offset": [151, 167]}], "samples": [{"hash": "ayhfe5ZY06h", "uri": "/contracts/ayhfe5ZY06h#licensed-product", "label": "Patent License Agreement", "score": 35.6948242188, "published": true}, {"hash": "iaOzV5oaZk6", "uri": "/contracts/iaOzV5oaZk6#licensed-product", "label": "Patent License Agreement (Aileron Therapeutics Inc)", "score": 35.0643386841, "published": true}, {"hash": "2oZEKNKwgPN", "uri": "/contracts/2oZEKNKwgPN#licensed-product", "label": "Patent License Agreement (TFF Pharmaceuticals, Inc.)", "score": 30.6317596436, "published": true}], "hash": "0544e89d5aeed547a6d71e60e981fa30", "id": 3}, {"size": 180, "snippet": "means any method, process, composition, product, service, or component part thereof that would, but for the granting of the rights set forth in this Agreement, infringe a Valid Claim contained in the Licensed Patents.", "snippet_links": [{"key": "component-part", "type": "definition", "offset": [61, 75]}, {"key": "the-rights", "type": "clause", "offset": [120, 130]}, {"key": "in-this-agreement", "type": "clause", "offset": [141, 158]}, {"key": "a-valid-claim", "type": "clause", "offset": [169, 182]}, {"key": "contained-in", "type": "definition", "offset": [183, 195]}, {"key": "licensed-patents", "type": "definition", "offset": [200, 216]}], "samples": [{"hash": "cNHrmq2denV", "uri": "/contracts/cNHrmq2denV#licensed-product", "label": "Exclusive License Agreement (Icosavax, Inc.)", "score": 34.6153335571, "published": true}, {"hash": "5Wjt9LcyDuW", "uri": "/contracts/5Wjt9LcyDuW#licensed-product", "label": "Non Exclusive License Agreement (Icosavax, Inc.)", "score": 33.2409324646, "published": true}, {"hash": "hjnTMrVICDq", "uri": "/contracts/hjnTMrVICDq#licensed-product", "label": "Exclusive License Agreement (Icosavax, Inc.)", "score": 32.5126609802, "published": true}], "hash": "9b1963d3933b087eab259be5e15a8749", "id": 4}, {"size": 102, "snippet": "means any product commercialized by a Licensee that embodies or utilizes Generated Information, a Subject Invention, or Copyrightable Work, or Other Intellectual Property.", "snippet_links": [{"key": "generated-information", "type": "definition", "offset": [73, 94]}, {"key": "subject-invention", "type": "clause", "offset": [98, 115]}, {"key": "copyrightable-work", "type": "definition", "offset": [120, 138]}, {"key": "other-intellectual-property", "type": "definition", "offset": [143, 170]}], "samples": [{"hash": "ezAzWB1uaTo", "uri": "/contracts/ezAzWB1uaTo#licensed-product", "label": "Budget Detail and Payment Provisions", "score": 27.5159511566, "published": true}, {"hash": "bRPa9g7nk0M", "uri": "/contracts/bRPa9g7nk0M#licensed-product", "label": "Budget Detail and Payment Provisions", "score": 26.1553726196, "published": true}, {"hash": "efVCohyGi1S", "uri": "/contracts/efVCohyGi1S#licensed-product", "label": "Budget Detail and Payment Provisions", "score": 24.1704311371, "published": true}], "hash": "5be3aa12bf7f61878f5136e3d0f761c8", "id": 5}, {"size": 89, "snippet": "means a Product comprising or containing one or more Licensed Compounds.", "snippet_links": [{"key": "licensed-compounds", "type": "definition", "offset": [53, 71]}], "samples": [{"hash": "cBlQ6dTV8Mr", "uri": "/contracts/cBlQ6dTV8Mr#licensed-product", "label": "Collaboration Agreement", "score": 31.3408622742, "published": true}, {"hash": "mNHm0OY40j", "uri": "/contracts/mNHm0OY40j#licensed-product", "label": "Collaboration Agreement (Discovery Partners International Inc)", "score": 21.0, "published": true}, {"hash": "i3bRX4mtKZe", "uri": "/contracts/i3bRX4mtKZe#licensed-product", "label": "Collaboration Agreement (Infinity Pharmaceuticals, Inc.)", "score": 21.0, "published": true}], "hash": "ab2e35fe03f9628efa32ab82b7b4931c", "id": 6}, {"size": 82, "snippet": "means any product that cannot be developed, manufactured, used, or sold without (a) infringing one or more claims under the Patent Rights, (b) using or incorporating some portion of one or more Biological Materials, or (c) using some portion of the Related Technology.", "snippet_links": [{"key": "claims-under", "type": "clause", "offset": [107, 119]}, {"key": "patent-rights", "type": "definition", "offset": [124, 137]}, {"key": "biological-materials", "type": "clause", "offset": [194, 214]}, {"key": "related-technology", "type": "definition", "offset": [249, 267]}], "samples": [{"hash": "lIKdS13qcoi", "uri": "/contracts/lIKdS13qcoi#licensed-product", "label": "Exclusive License Agreement (Cytrx Corp)", "score": 21.0, "published": true}, {"hash": "kMJyzyf6vWh", "uri": "/contracts/kMJyzyf6vWh#licensed-product", "label": "Exclusive License Agreement (Cytrx Corp)", "score": 21.0, "published": true}, {"hash": "jYDdVqkKcCC", "uri": "/contracts/jYDdVqkKcCC#licensed-product", "label": "Exclusive License Agreement (Cytrx Corp)", "score": 21.0, "published": true}], "hash": "d93e3d3e90d289704c0ce2c391ff547f", "id": 7}, {"size": 75, "snippet": "means any product, the manufacture or sale of which is within a Valid Claim within the Licensed Patents in the country of manufacture or sale.", "snippet_links": [{"key": "sale-of", "type": "clause", "offset": [38, 45]}, {"key": "a-valid-claim", "type": "clause", "offset": [62, 75]}, {"key": "licensed-patents", "type": "definition", "offset": [87, 103]}, {"key": "country-of-manufacture", "type": "clause", "offset": [111, 133]}], "samples": [{"hash": "4D7IpSC5BND", "uri": "/contracts/4D7IpSC5BND#licensed-product", "label": "License Agreement (Illumina Inc)", "score": 21.0, "published": true}, {"hash": "eYPdkVE3JSQ", "uri": "/contracts/eYPdkVE3JSQ#licensed-product", "label": "License Agreement (Illumina Inc)", "score": 18.0, "published": true}, {"hash": "b16bykaXdDH", "uri": "/contracts/b16bykaXdDH#licensed-product", "label": "License Agreement (Illumina Inc)", "score": 18.0, "published": true}], "hash": "cf898027b7072b01e47b522f4d28479c", "id": 8}, {"size": 66, "snippet": "means any material for which the manufacture, use, sale, or import would constitute an infringement of a Valid Claim within the Regents\u2019 Patent Rights if not for the license granted to the Licensee under this Agreement.", "snippet_links": [{"key": "infringement-of", "type": "clause", "offset": [87, 102]}, {"key": "a-valid-claim", "type": "clause", "offset": [103, 116]}, {"key": "the-regents", "type": "clause", "offset": [124, 135]}, {"key": "patent-rights", "type": "definition", "offset": [137, 150]}, {"key": "granted-to", "type": "clause", "offset": [174, 184]}, {"key": "the-licensee", "type": "definition", "offset": [185, 197]}, {"key": "this-agreement", "type": "clause", "offset": [204, 218]}], "samples": [{"hash": "j8lVXiM7Jtq", "uri": "/contracts/j8lVXiM7Jtq#licensed-product", "label": "Financing Agreement (NeurogesX Inc)", "score": 21.6078033447, "published": true}, {"hash": "fSTa5hATn5Q", "uri": "/contracts/fSTa5hATn5Q#licensed-product", "label": "Exclusive License Agreement (NeurogesX Inc)", "score": 21.0, "published": true}, {"hash": "a8ZjNtAn2ro", "uri": "/contracts/a8ZjNtAn2ro#licensed-product", "label": "Distribution Agreement (NeurogesX Inc)", "score": 21.0, "published": true}], "hash": "65db5c9b242847844435d99128cd701e", "id": 9}, {"size": 65, "snippet": "means any product that is comprised of or contains a Licensed Compound [***], alone or in combination with one or more other active ingredients, in any and all forms, presentations, dosages and formulations.", "snippet_links": [{"key": "comprised-of", "type": "clause", "offset": [26, 38]}, {"key": "licensed-compound", "type": "definition", "offset": [53, 70]}, {"key": "in-combination", "type": "definition", "offset": [87, 101]}, {"key": "other-active-ingredients", "type": "clause", "offset": [119, 143]}], "samples": [{"hash": "5tR94tzvTnb", "uri": "/contracts/5tR94tzvTnb#licensed-product", "label": "License Agreement (Ovid Therapeutics Inc.)", "score": 33.0054740906, "published": true}, {"hash": "K4xO6NG3S8", "uri": "https://d18rn0p25nwr6d.cloudfront.net/CIK-0001636651/a9eaa618-1157-467f-b8b8-1240ab0bcd3a.pdf", "label": "d18rn0p25nwr6d.cloudfront.net", "score": 11.4257354736, "published": false}, {"hash": "i9GQkh11pSj", "uri": "https://investors.ovidrx.com/static-files/3fb0cffd-53db-4fd3-be41-d2ccbd7966cb", "label": "investors.ovidrx.com", "score": 11.002737999, "published": false}], "hash": "0a4ed4130da4ffdea4ecd1f0f2bc346c", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZbGljZW5zZWQtcHJvZHVjdCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"title": "Licensed Product", "size": 7955, "snippet": "means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.", "id": "licensed-product", "examples": ["For the avoidance of doubt, a <strong>Licensed Product</strong> includes a complete system, which may include hardware, software, accessories, implementation manuals and the like, or a sub-system of a complete system, incorporating the Technology (or part thereof).", "Eisai shall financially book all sales of the <strong>Licensed Product</strong> in the Territory.", "Within [***] days of the Effective Date, the Parties shall each appoint (a) one person to coordinate its activities under this Agreement (each an \u201cAlliance Manager\u201d) and (b) an equal number of, and in any case no more than [***] senior executives to establish a joint collaboration committee (the \u201cJCC\u201d), which will act as a forum for information exchange, monitoring, and discussion of issues, best practices, and ideas with respect to any <strong>Licensed Product</strong> in the Territory.", "Upon Marketing Approval of a <strong>Licensed Product</strong>(s) in the Territory for the Initial Indication, Eisai shall, either directly or through its Affiliates, Sublicensees or Distributors, use Commercially Reasonable Efforts to Commercialize at least one <strong>Licensed Product</strong> in the Field in the Territory in accordance with the approved labeling therefor.", "Upon [***] request, [***] shall assist and cooperate in such enforcement, including by providing any information regarding technical details or other knowledge related to the Licensed Compound or any <strong>Licensed Product</strong> in the Territory, at [***] sole cost and expense.", "Each Party shall promptly notify the other Party if it becomes aware of any Third Party Know-How or Patents that are necessary to Develop, Manufacture or Commercialize a <strong>Licensed Product</strong> in the Territory (the \u201cThird Party IP\u201d).", "On a <strong>Licensed Product</strong>-by-<strong>Licensed Product</strong> and country-by-country basis, [***], the royalty rate applicable to Net Sales of such <strong>Licensed Product</strong> in such country shall be reduced by [***] for the remainder of the Royalty Term in such country in respect of such <strong>Licensed Product</strong>.", "Subject to Section 6.3, the Parties agree \u2587\u2587\u2587\u2587\u2587 retains sole and complete decision-making authority as to whether to launch a <strong>Licensed Product</strong> in a country of the Territory.", "On a <strong>Licensed Product</strong>-by-<strong>Licensed Product</strong> and country-by-country basis, in the event a <strong>Licensed Product</strong> is generating Net Sales in a country in the Territory during the Royalty Term at a time when such <strong>Licensed Product</strong> [***] in such country, then the royalty rate applicable to Net Sales of such <strong>Licensed Product</strong> in such country shall be reduced by [***].", "For any Clinical Trial in any country or countries in the Territory for a <strong>Licensed Product</strong> other than the AB-106-G319 Study or [***] (a \u201cNew Indication Study\u201d), subject to approval by the JCC with respect to a study plan and the Parties\u2019 mutual agreement in writing with respect to a corresponding budget for such New Indication Study, Eisai and Nuvation shall share the costs of such New Indication Study on a [***] basis."], "related": [["licensed-products", "Licensed Products", "<strong>Licensed Products</strong>"], ["collaboration-product", "Collaboration Product", "Collaboration Product"], ["diagnostic-product", "Diagnostic Product", "Diagnostic Product"], ["hemp-product", "Hemp product", "Hemp product"], ["licensed-producer", "Licensed producer", "Licensed producer"]], "related_snippets": [], "updated": "2026-05-08T06:30:32+00:00"}, "json": true, "cursor": ""}}